about
A new tool to further explore the role of ADAMTS-13 in health and disease.Predictors of response and relapse in a cohort of adults with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: a single-institution experience.National survey of hemapheresis practice in Hungary 2001-2004.Prevalence of the ADAMTS-13 missense mutation R1060W in late onset adult thrombotic thrombocytopenic purpura.Rituximab in the treatment of autoimmune haematological disorders.[Thrombotic microangiopathy after extracorporeal circulation: important differential diagnosis].Systemic lupus erythematosus presenting as thrombotic thrombocytopenia purpura: how close is close enough?Congenital thrombotic thrombocytopenia presenting with placental abruption.Circulating DNA and myeloperoxidase indicate disease activity in patients with thrombotic microangiopathies.A phenotype-genotype correlation of ADAMTS13 mutations in congenital thrombotic thrombocytopenic purpura patients treated in the United Kingdom.Thrombotic microangiopathy in sickle cell disease crisis.Unresponsive thrombotic thrombocytopenic purpura in critically ill adults.Relapses of thrombotic thrombocytopenic purpura after treatment with rituximab.ADAMTS-13 in the Diagnosis and Management of Thrombotic Microangiopathies.Impaired DNase1-mediated degradation of neutrophil extracellular traps is associated with acute thrombotic microangiopathies.Von Willebrand factor-cleaving protease activity in thrombotic microangiopathy: first report from iranADAMTS13 Endopeptidase Protects against Vascular Endothelial Growth Factor Inhibitor-Induced Thrombotic Microangiopathy.Extracellular matrix proteins in hemostasis and thrombosisThe evaluation and management of postnatal thromboses.Benefits and limitations of plasmapheresis in renal diseases: an evidence-based approach.Platelet signaling-a primer.Evaluating the impact of the ABO blood group on the clinical outcome of thrombotic thrombocytopenic purpura associated with severe ADAMTS13 deficiency.The Role of Frontal-Subcortical Circuitry in Neuropsychological Deficit of Attention: Hypothesis and Results in Two Coagulation Disorders.Atypical Hemolytic Uremic Syndrome: Differential Diagnosis from TTP/HUS and Management.IL-1β down-regulates ADAMTS-13 mRNA expression in cells of the central nervous system.Thrombospondin-1 controls vascular platelet recruitment and thrombus adherence in mice by protecting (sub)endothelial VWF from cleavage by ADAMTS13.ADAMTS-13 and Von Willebrand factor in relation to platelet response during plasma exchange in thrombotic thrombocytopenic purpura: a clue for disease mechanism?Thrombotic Thrombocytopenic Purpura Associated with DermatomyositisADAMTS13 activity to antigen ratio in physiological and pathological conditions associated with an increased risk of thrombosisThrombotic thrombocytopenic purpuraThrombotic thrombocytopenic purpura as the first presentation in systemic lupus erythematosus
P2860
Q33371176-31E4C8E4-5AAF-4B46-A0A1-DEA9E2FC2902Q33373783-759A092F-F8E5-4329-A0B5-0EA4E4F6E803Q33374298-D6649DE5-5F2F-4C22-B4AC-BC3D637D3828Q33377517-494FB173-F33C-45B5-9864-52492D57632EQ33378854-7F733D6F-0792-4AB9-83F9-195E6054FBD0Q33393404-E3B2F41C-E850-4D27-AB55-6C69EC102CF6Q33395602-18FA598F-1B2D-49AB-B820-4B5BAD5A912FQ33399924-91D36A1A-9754-4B37-B378-7093E8DA47ACQ33401314-D06D1163-A3B0-451C-BD7D-D8AD11849726Q33402274-0451A678-D96F-40C1-B456-52641377FA99Q33404745-6644ED22-37F6-4B1B-9602-2F13A55DA1F8Q33406785-FF2BC182-EC21-4F8D-B2E0-57085B6F2043Q33409112-D87911CD-28B4-4FD6-AC1E-1CBA0AA4A49AQ33418645-8096F98D-5B40-4EC9-9F98-D16E952CF6A0Q33418811-89E41714-2E56-457A-87BE-97232B489FAFQ33420881-6A99BF48-23AE-466C-BA09-B1A385CB4AF6Q33423350-FA92443B-815D-4608-B787-E04545201264Q35762807-893392C5-D560-4614-A692-AC0957C057A7Q37412926-70DA97CB-28E2-4F4F-A955-37BC239791BAQ37820338-1CB45F96-5754-424B-8991-F9E02D12E125Q37982455-F6ED6F5A-190C-401F-AB75-4D7CF9042AC0Q38736033-037910D4-7BBF-4C96-9BE7-B7606FD7FAD2Q38852268-3BC6EF66-703B-44E4-98AF-0894884E3B97Q39112532-572191B7-F523-46FA-970C-A2ACED703564Q39512224-5467BA93-8F63-43EA-A29F-3AC215E5B5A5Q42194066-46C30617-C8E4-4A4D-A607-7C48832242FEQ43067247-C90E84B9-621E-40C6-8BF2-3BE5A0713D5FQ57823737-28402EC1-DC3A-443C-931E-175978099E8EQ58481440-15E4228A-4F7B-4628-B26C-A8472EE097E0Q58767790-31EC5C8A-BD85-4E2F-AB08-06EF702D10C9Q58779824-B318D31C-ACA8-4149-9091-0D8DAA91FBBE
P2860
description
im August 2005 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 August 2005
@en
наукова стаття, опублікована в серпні 2005
@uk
name
Thrombotic thrombocytopenic purpura
@en
type
label
Thrombotic thrombocytopenic purpura
@en
prefLabel
Thrombotic thrombocytopenic purpura
@en
P2860
P1476
Thrombotic thrombocytopenic purpura
@en
P2093
P2860
P304
P356
10.1111/J.1538-7836.2005.01425.X
P577
2005-08-01T00:00:00Z